LEADER 01313nam0 2200325 i 450 
001 SUN0127247
005 20200303092319.731
010   $d0.00
017 70$2N$a978-88-470-3993-3
100   $a20200303d2019       |0itac50      ba
101   $aita
102   $aIT
105   $a||||    |||||
200 1 $a*Algebra lineare ed equazioni differenziali ordinarie$fCesare Parenti, Alberto Parmeggiani
205   $a2. ed
210   $aMilano$cSpringer$d2019
215   $axii, 228 p.$d24 cm
410  1$1001SUN0045576$12001 $a*Unitext$1210  $aMilano$cSpringer$d1985-.
606   $a15-XX$xLinear and multilinear algebra; matrix theory [MSC 2020]$2MF$3SUNC020607
606   $a34-XX$xOrdinary differential equations [MSC 2020]$2MF$3SUNC021251
620   $dMilano$3SUNL000284
700  1$aParenti$b, Cesare$3SUNV078692$056567
701  1$aParmeggiani$b, Alberto$3SUNV052095$0478937
712   $aSpringer$3SUNV000178$4650
801   $aIT$bSOL$c20210503$gRICA
856 4 $uhttp://doi.org/10.1007/978-88-470-3993-3
912   $aSUN0127247
950   $aUFFICIO DI BIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA$d08CONS      e-book                  1802        $e08eMF1802              20200303            
996   $aAlgebra lineare ed equazioni differenziali ordinarie$91411339
997   $aUNICAMPANIA

LEADER 02568nam  2200565 a 450 
001 9910785115503321
005 20230828215644.0
010   $a1-282-80173-2
010   $a9786612801730
010   $a1-4416-6139-5
010   $a93-5043-529-2
010   $a600-00-2715-X
035   $a(CKB)2670000000047479
035   $a(EBL)588365
035   $a(OCoLC)700692367
035   $a(SSID)ssj0000672353
035   $a(PQKBManifestationID)11415321
035   $a(PQKBTitleCode)TC0000672353
035   $a(PQKBWorkID)10635189
035   $a(PQKB)10381738
035   $a(MiAaPQ)EBC588365
035   $a(Au-PeEL)EBL588365
035   $a(CaPaEBR)ebr10416258
035   $a(EXLCZ)992670000000047479
100   $a20101015d2006      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aBiopharmaceuticals$b[electronic resource] /$fS.N. Jogdand
205   $a1st ed.
210   $aMumbai [India] $cHimalaya Pub. House$d2006
215   $a1 online resource (283 p.)
300   $aDescription based upon print version of record.
311   $a81-8318-620-3 
320   $aIncludes bibliographical references and index.
327   $aCOVER; CONTENTS; INTRODUCTION; MARKET FOR BIOPHARMACEUTICALS; BIOPHARMACEUTICAL INDUSTRY; BIOPHARMACEUTICAL SECTOR IN INDIA; DRUG DISCOVERY AND DRUG DESIGNING; PHARMACOKINETICS; CLINICAL TRIALS; REGULATORY; THERAPEUTIC PROTEINS; BLOOD PRODUCTS; MONOCLONAL ANTIBODIES; HORMONE THERAPY; VACCINE PRODUCTION-NEW DEVELOPMENTS; TRANSGENIC PRODUCTION OF BIOPHARMACEUTICALS; HUMAN GENE THERAPY; ANTISENSE TECHNOLOGY (DNA MEDICINES)
330   $aBiopharmaceuticals are complex macromolecules created through the genetic manipulation of living organisms using gene cloning, recombinant DNA(gene splicing), or fusion technologies. Although small molecule drugs remain the standard treatment for disease, new strategies based on the engineering of proteins, genes and cell as therapeutic agents will revolutionize medicine in the coming decades. More than 20 percent of new medicines launched in 2003 were produced using biotechnology, nearly 80 percent of those under development either use use of biotechnology or are derived from it. The biopharm
606   $aBiopharmaceutics
615  0$aBiopharmaceutics.
676   $a615/.7
700   $aJogdand$b S. N$01478028
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910785115503321
996   $aBiopharmaceuticals$93725726
997   $aUNINA